Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

NCT07015333 · clinicaltrials.gov ↗

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Oral Squamous Cell Carcinoma (OSCC)

Interventions

DRUG: pembrolizumab and cetuximab

Sponsor

Commonwealth Healthcare Corporation